Published on 19 Jul 2024 on Benzinga · via Yahoo Finance
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has...
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
William Blair initiated coverage on Applied Therapeutics Inc. (NASDAQ:APLT), a late-stage development company focused on rare diseases such as galactosemia, SORD deficiency, and diabetic cardiomyopathy.
The analyst says, “Applied Therapeutics is an under-the-radar company developing a nice mix of therapeutics targeting rare diseases and some larger indications with potential for several major value inflections over the next 12 months.”